Creo Medical (GB:CREO) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Creo Medical Group has reported its total issued share capital to be 412,148,979 ordinary shares, each carrying a single voting right. This announcement aids shareholders in understanding their voting power and compliance with financial regulations. Creo is recognized for its innovative minimally invasive electrosurgical devices that promise enhanced surgical precision and patient outcomes.
For further insights into GB:CREO stock, check out TipRanks’ Stock Analysis page.
